The lack of response to this - and it can only be described as - catastrophic demise of the SP, by MSB to the market is unfathomable.
I'm going to guess, but it's an educated guess, that this will be SI's last quarter as CEO.
I think a big upheaval at the top is happening in real time, and that there will be a new team to grow MSB from a 'wannabe' biotech to fully fledged drug manufacturing company.
$3.35 down to $2.08 gets any CEO the boot, especially one who has burnt it's shareholders so spectacularly over the last decade.
GG knows how to launch a business, and JB knows how to manage one.
Luckily, they both also know when to go and make changes and recruit new, and proven, management.
It's time for SI to shuffle off back into the lab and let genuine business people take over.
MSB Price at posting:
$2.07 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)